Ayahuasca and Kambo intoxication after alternative natural therapy for depression, confirmed by mass spectrometry

[1]  V. Fineschi,et al.  The Biological Effects of Kambo: Is There a Relationship Between its Administration and Sudden Death? , 2018, Journal of forensic sciences.

[2]  B. Greenberg,et al.  Transcranial magnetic stimulation for treatment-resistant depression: Naturalistic treatment outcomes for younger versus older patients. , 2017, Journal of affective disorders.

[3]  A. Zangen,et al.  61% of unmedicated treatment resistant depression patients who did not respond to acute TMS treatment responded after four weeks of twice weekly deep TMS in the Brainsway pivotal trial , 2017, Brain Stimulation.

[4]  A. Pic-Taylor,et al.  Reproductive effects of the psychoactive beverage ayahuasca in male Wistar rats after chronic exposure , 2017 .

[5]  C. E. Hart,et al.  Effectiveness of hypnosis therapy and Gestalt therapy as depression treatments , 2017 .

[6]  D. Vancampfort,et al.  Treatment Guidelines for Depression: Greater Emphasis on Physical Activity is Needed , 2017, European Psychiatry.

[7]  M. Brvar,et al.  The syndrome of inappropriate antidiuretic hormone secretion after giant leaf frog (Phyllomedusa bicolor) venom exposure. , 2016, Toxicon : official journal of the International Society on Toxinology.

[8]  M. Yonamine,et al.  Ritualistic Use of Ayahuasca versus Street Use of Similar Substances Seized by the Police: A Key Factor Involved in the Potential for Intoxications and Overdose? , 2015, Journal of psychoactive drugs.

[9]  S. Bloom,et al.  Neurokinin B Administration Induces Hot Flushes in Women , 2015, Scientific Reports.

[10]  M. Bronkhorst,et al.  Phyllomedusa bicolor skin secretion and the Kambô ritual , 2014, Journal of Venomous Animals and Toxins including Tropical Diseases.

[11]  D. I. Brierley,et al.  Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[12]  Rafael Menck de Almeida,et al.  Determination of dimethyltryptamine and β-carbolines (ayahuasca alkaloids) in plasma samples by LC-MS/MS. , 2012, Bioanalysis.

[13]  K. Feeney,et al.  Ayahuasca and the process of regulation in Brazil and internationally: implications and challenges. , 2012, The International journal on drug policy.

[14]  S. Moura,et al.  Gas chromatographic analysis of dimethyltryptamine and beta-carboline alkaloids in ayahuasca, an Amazonian psychoactive plant beverage. , 2009, Phytochemical analysis : PCA.

[15]  J. Landeira-Fernández,et al.  Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members. , 2007, Journal of ethnopharmacology.

[16]  B. Levine,et al.  A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation. , 2005, Journal of analytical toxicology.

[17]  D. Mckenna.  Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. , 2004, Pharmacology & therapeutics.

[18]  M. Ko,et al.  Characterization of scratching responses in rats following centrally administered morphine or bombesin , 2003, Behavioural pharmacology.

[19]  J. Callaway,et al.  Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca. , 1996, Journal of analytical toxicology.

[20]  D. Barra,et al.  Pharmacological studies of 'sapo' from the frog Phyllomedusa bicolor skin: a drug used by the Peruvian Matses Indians in shamanic hunting practices. , 1993, Toxicon : official journal of the International Society on Toxinology.

[21]  Ismael Apud,et al.  Medicine, religion and ayahuasca in Catalonia. Considering ayahuasca networks from a medical anthropology perspective. , 2017, The International journal on drug policy.

[22]  D. Araujo,et al.  Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report. , 2015, Revista brasileira de psiquiatria.

[23]  R. Clement.  Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites (Parts 1, 2, 3) , 1994 .

[24]  Karl Pfleger,et al.  Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites: Part 3 mass spectra (m/z222 to 777 amu). , 1992 .

[25]  V. Erspamer,et al.  Active peptides in the skins of two hundred and thirty American amphibian species. , 1986, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology.

[26]  V. Ferreira Montero,et al.  Usefulness of caerulein in the treatment of post-operative intestinal atony. , 1980, The Journal of international medical research.

[27]  M. Musiani,et al.  N-Permethylation of Primary and Secondary Aromatic Amines , 1980 .